Roche Completes $1.4-Bn Acquisition of Biopharma Company Promedior
By
Roche has completed its previously announced acquisition of Promedior, a Lexington, Massachusetts-based clinical-stage biopharmaceutical company focused on developing drugs for fibrotic diseases, in an approximate $1.4-billion deal (upfront cash payment…
Astellas’ Audentes to Build Gene-Therapy Mfg Facility
By
Audentes Therapeutics, an Astellas company focused on developing adeno-associated virus-based genetic medicines, plans to invest $109 million to build a new 135,000-square-foot gene-therapy manufacturing facility in Sanford, North Carolina. The…